09.07.2013 - 09.10.2013
The Joint Technology Initiative "Innovative Medicines Initiative" published its 9th Call of Proposals.
Deadline: 9 October 2013 (17:00 Brussels time) for Expressions of Interest
Publication Date: 9 July 2013
Weblink (URL): http://www.imi.europa.eu/content/stage-1-7
Short Call Abstract:
The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a unique pan-European public private partnership between the European Commission and EFPIA1 driving
collaboration between all relevant stakeholders including large and small biopharmaceutical and healthcare companies, regulators, academia, and patients.
The IMI 9th Call 2013 for proposals includes topics covering the following key research priorities:
- Knowledge Management (correlated to the area of interest: Knowledge, Patient, Development)
- Coping with Regulatory and Legal Hurdles (correlated to the area of interest: Development)
- Beyond Drug Discovery: Drug Development and the Regulatory Framework (correlated to the area of interest: Development)
- Infectious diseases (correlated to the area of interest: Disease Drug Efficacy)
SSH aspects can be found under the following Call topic: “ND4BB TOPIC 4: Driving re-investment in R&D and Responsible Use of Antibiotics”. SSH aspects include:
Economic modeling, development of commercial model case studies and analytics, analysis of societal impact of antibiotic resistance/cost to societies, public health perspectives
Specific participation requirements:
For learning more about eligibility criteria, please refer to the Rules for participation in the IMI JU collaborative projects published on the IMI JU website www.imi.europa.eu.